 |
| 272. |
Sheppard, B.C., Norton, J.A., Doppman, J.L., Maton, P.N., Gardner, J.D. and Jensen, R.T. Management of islet cell tumors in patients with multiple endocrine neoplasia (MEN): a prospective study. Surgery 106: 1108-1117, 1989. |
| 271. |
Maton, P.N., Gardner, J.D. and Jensen, R.T. Recent advances in management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. In: Gastroenterology Clinics of North America. (R.T. Jensen, ed.). W.B. Saunders Co., Philadelphia, PA, 1989, 18: 847-863. |
| 270. |
Jensen, R.T., von Schrenck, T., Yu, D-H., Wank, S.A. and Gardner, J.D. Pancreatic cholecystokinin (CCK) receptors: comparison with other classes of CCK receptors. In: The Neuropeptide Cholecystokinin (CCK). (Hughes, Dockray and Woodruff, eds.). Ellis Horwood, Ltd., West Sussex, England, 1989, pp.150-162 |
| 269. |
Maton, P.N., Vinayek, R., Frucht, H., McArthur, K.A., Miller, L.S., Saeed, Z.A., Gardner, J.D. and Jensen, R.T. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Gastroenterology 97: 827-836, 1989. |
| 268. |
Qian, J-M., Coy, C.H., Jiang, N.Y., Gardner, J.D. and Jensen, R.T. Reduced peptide bond pseudopeptide analogues of substance P. J. Biol. Chem. 264: 16667-16671, 1989. |
| 267. |
Maton, P.N., Lack, E., Vinayek, R., Collen, M.J., Frucht, H., Miller, L.S., Gardner, J.D. and Jensen, R.T. Prospective assessment of the safety and efficacy of long-term omeprazole therapy in patients with Zollinger-Ellison syndrome. Scand. J. Gastroenterol 24: 181, 1989. |
| 266. |
Frucht, H., Howard, J.M., Slaff, J.I., McCarthy, D.M., Maton, P.N., Wank, S.A., Vinayek, R., Gardner, J.D. and Jensen, R.T. Secretin and calcium provocative tests in Zollinger-Ellison syndrome. Ann. Int. Med. 111: 713-722, 1989. |
| 265. |
Saeed, Z.A., Huang, S.C., Coy, D.H., Jiang, N.Y., Heinz-Erian, P., Mantey, S., Gardner, J.D. and Jensen, R.T. Effect of substitutions in position 12 of bombesin on antagonist activity. Peptides 10: 597-603, 1989. |
| 264. |
Menozzi, D., Stark, H.A., Martinez, J., Jensen, R.T. and Gardner, J.D. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low-affinity CCK receptors. Peptides 10: 337-341, 1989. |
| 263. |
Maton, P.N., Norton, J.A., Nieman, L., Doppman, J.L., Gardner, J.D. and Jensen, R.T. Multiple endocrine neoplasia Type-2 with Zollinger-Ellison syndrome caused by solitary pancreatic gastrinoma. JAMA 262: 535-537, 1989. |
| 262. |
Murakami, M., Vinayek, R., Jensen, R.T. and Gardner, J.D. Carbachol-induced down-regulation of high affinity receptors for vasoactive intestinal peptide. Am. J. Physiol. 257: G402-G408, 1989 |
| 261. |
Sutliff, V.E., Rattan, S., Gardner, J.D. and Jensen, R.T. Characterization of cholinergic receptors mediating pepsinogen secretion from chief cells. Am. J. Physiol. 257: G226-G234, 1989. |
| 260. |
Huang, S.C., Zhang, L., Chiang, H-C.V., Wank, S.A., Maton, P.N., Gardner, J.D. and Jensen, R.T. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists. Am. J. Physiol. 257: G169-G174, 1989. |
| 259. |
Menozzi, D., Gardner, J.D., Jensen, R.T. and Maton. P.N. Properties of receptors for gastrin and cholecystokinin on gastric smooth muscle cells. Am. J. Physiol. 257: G73-G79, 1989.
|
| 258. |
Huang, S-C., Yu, D-H., Wank, S.A., Mantey, S., Gardner, J.D, and Jensen, R.T. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides 10: 785-789, 1989. |
| 257. |
Maton, P.N., Mackem, S.H., Norton, J.A., Gardner, J.D., O'Dorisio, T.M. and Jensen, R.T. Ovarian carcinoma as a cause of Zollinger-Ellison syndrome: Natural history, secretory products and response to provocative tests. Gastroenterology 97: 468-471, 1989. |
| 256. |
Gardner, J.D. and Jensen, R.T. Pancreatic acini as second messenger models in exocrine secretion. In: Methods in Enzymology, Biomembranes and Biological Transport. (S. Fleischer and B. Fleischer, eds.). Academic Press, Inc., New York, NY, 1989, pp.590-594. |
| 255. |
Gardner, J.D. and Jensen, R.T. Receptors for gut peptides and other secretagogues on pancreatic acinar cells. In: Handbook of Physiology. Am. J. Physiol. 1989, pp.171-192.
|
| 254. |
Coy, D.H., Heinz-Erian, P., Jiang, N-Y., Taylor, J., Moreau, J-P., Gardner, J.D. and Jensen, R.T. Progress in the development of competitive bombesin antagonists. Ann. N.Y. Acad. Sci. 547: 150-157, 1989. |
| 253. |
Sato, S., Stark, H.A., Martinez, J., Beaven, M.A., Jensen, R.T. and Gardner, J.D. Receptor occupation, calcium mobilization and amylase release in pancreatic acini: effect of CCK-JMV-180. Am. J. Physiol. 257: G202-G209, 1989. |
| 252. |
Maton, P.N., Gardner, J.D. and Jensen, R.T. Diagnosis and management of Zollinger-Ellison syndrome. In: Endocrinology and Metabolism Clinics of North America, 18. Plenum Publishing Corp., New York, NY, 1989, pp.519-543. |
| 251. |
Saeed, Z.A., Norton, J.A., Frank, W.O., Young, M.D., Gardner, J.D. and Jensen, R.T. Parenteral antisecretory drug therapy in patients with Zollinger-Ellison syndrome. Gastroenterology 96: 1393-1402, 1989. |
| 250. |
Maton, P.N., Gardner, J.D. and Jensen, R.T. Use of long-acting somatostatin analog SMS201-995 in patients with pancreatic islet cell tumors. Dig. Dis. Sci. 34: 28S-39S, 1989. |
| 249. |
von Schrenck, T., Heinz-Erian, P., Moran, T., Mantey, S.A., Gardner, J.D. and Jensen, R.T. Neuromedin B receptor in esophagus: evidence for subtypes of bombesin receptors. Am. J. Physiol. 256: G747-G758, 1989. |
| 248. |
Menozzi, D., Sato, S., Jensen, R.T. and Gardner, J.D. Cyclic GMP does not inhibit protein kinase C-mediated enzyme secretion in rat pancreatic acini. J. Biol. Chem. 264: 995-999, 1989. |
|
 |
|
|
